FDA Investigator

Gabrielle J Swain

Latest inspection on record: Seodaemun, South Korea, June 2026 · records back to 2019

Human DrugsMedical Devices & Rad HealthBiologicsAnimal Drugs & Feeds

FDA inspection record · Last updated August 15, 2026

Overview

  • 86 inspections across 77 sites are on record.
  • 24 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-12.

At a glance

Inspections

86

Sites

77

Observations

24

Career since

Oct 2019

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Sun Young Rha, M.D., Ph.D.12 Jun 2026Human Drugs
Ying Liu, M.D.5 Jun 2026Human Drugs
Robert Sarsfield, DVM21 May 2026Animal Drugs & Feeds
Coby E Rudakewiz DVM15 May 2026Animal Drugs & Feeds
Madrigal Pharmaceutical, Inc8 May 2026Human Drugs

Sites inspected

Sun Young Rha, M.D., Ph.D.Seodaemun, Korea (the Republic of)1 insp.
Ying Liu, M.D.Zhengzhou City, China1 insp.
Robert Sarsfield, DVMHarrisburg, United States1 insp.
Coby E Rudakewiz DVMHarrisburg, United States1 insp.
Madrigal Pharmaceutical, IncConshohocken, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Daniel P Laucks1 shared
Kerun Hardeo1 shared

Full investigator report

Get the verbatim findings behind Gabrielle J Swain's 24 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site